Bone Biologics Stock Forecast

Buy or Hold candidate since Jun 16, 2026 Loss -2.90%

The Bone Biologics Corporation stock price fell by -8.84% on the last day (Wednesday, 8th Jul 2026) from $1.47 to $1.34. During the last trading day the stock fluctuated 7.14% from a day low at $1.26 to a day high of $1.35. The price has been going up and down for this period, and there has been a -2.9% loss for the last 2 weeks. Volume has increased on the last day by 338 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 358 thousand shares were bought and sold for approximately $480.34 thousand.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.17% during the next 3 months and, with a 90% probability hold a price between $1.32 and $1.55 at the end of this 3-month period.

BBLG Signals & Forecast

The Bone Biologics Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.40. On a fall, the stock will find some support from the long-term average at approximately $1.32. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -8.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Bone Biologics Corporation gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Bone Biologics Corporation stock

Bone Biologics Corporation finds support from accumulated volume at $1.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0900 between high and low, or 7.14%. For the last week, the stock has had daily average volatility of 6.68%.

Our recommended stop-loss: $1.27 (-5.08%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (BBLG) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect Bone Biologics Corporation to open at $1.32, and during the day (based on 14 day Average True Range), to move between $1.29 and $1.39, which gives a possible trading interval of +/-$0.0947 (+/-7.33%) up or down from last closing price. If Bone Biologics Corporation takes out the full calculated possible swing range there will be an estimated 7.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.32 (1.49%) than the resistance at $1.44 (7.46%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bone Biologics Corporation stock A Buy?

Bone Biologics Corporation holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.420 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 9, 2026 - $1.32 ( 1.74%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk